ETFs Holding ADVM

For investors looking for the best ETF with ADVM, use this page to see which ETFs hold ADVM, Adverum Biotechnologies Inc, and how much exposure each fund has to the stock. For investors comparing ETF holdings, this is one of the fastest ways to see where Adverum Biotechnologies Inc shows up across broad market funds, growth versus value funds, sector ETFs, and other strategies.

The data below shows the number of ETFs holding ADVM, the total market value of those holdings, and the weight Adverum Biotechnologies Inc carries inside individual funds. For quick use, jump straight to the holdings table. For broader ETF research, use the ETF Finder and related tools across ETF Channel.

ADVM Description — Adverum Biotechnologies Inc

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company. Co. discovers and develops gene therapy product candidates that provides durable efficacy by inducing sustained expression of a therapeutic protein. Its lead product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable levels of aflibercept associated with a sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) IVT injections.
Company Name:  Adverum Biotechnologies Inc
Website:  www.adverum.com
Sector:  Biotechnology

Browse ETF screens, holdings-related research, dividend and yield pages, analyst screens, and related market idea pages from across the channel network. These links are grouped by topic to make the list easier to scan.

Dividend, Yield, and Income Research

Dividend and income-oriented screens that are relevant to ETF investors comparing holdings, yield exposure, and stock selection ideas.

Energy, Metals, and Canada Research

Cross-network sector research pages that may be useful for investors following ETF exposure to energy, metals, and Canadian markets.